| Use of lipid-modulating drugs in complicated course of coronary heart disease. | |
| | |
MedLine Citation:
|
PMID: 18457052 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
We present the results of the study of lipid-modulating drugs (pravastatin, atorvastatin, simvastatin, and fibrate gemfibrozil) in complicated coronary heart disease (acute coronary syndrome without ST elevation, chronic heart failure. In acute coronary syndrome statins produced a positive effect on some studied parameters, while in heart failure only the safety of short-term therapy with statins was demonstrated. |
| | |
Authors:
|
N A Gratsianskii; N A Vaulin |
Publication Detail:
|
Type: Clinical Trial; Journal Article |
Journal Detail:
|
Title: Bulletin of experimental biology and medicine Volume: 144 ISSN: 0007-4888 ISO Abbreviation: Bull. Exp. Biol. Med. Publication Date: 2007 Sep |
Date Detail:
|
Created Date: 2008-05-06 Completed Date: 2008-06-20 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0372557 Medline TA: Bull Exp Biol Med Country: United States |
Other Details:
|
Languages: eng Pagination: 438-46 Citation Subset: IM |
Affiliation:
|
Laboratory of Clinical Cardiology, Institute of Physicochemical Medicine, Federal Agency on Health Care and Social Development, Moscow. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Antilipemic Agents
/
therapeutic use* Antithrombin III / metabolism Cholesterol, LDL / metabolism Coronary Disease / drug therapy* Echocardiography Female Gemfibrozil / therapeutic use Heptanoic Acids / therapeutic use Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use* Male Peptide Hydrolases / metabolism Pravastatin / therapeutic use Prothrombin / metabolism Pyrroles / therapeutic use Simvastatin / therapeutic use von Willebrand Factor / metabolism |
| Chemical | |
Reg. No./Substance:
|
0/Antilipemic Agents; 0/Cholesterol, LDL; 0/Heptanoic Acids; 0/Hydroxymethylglutaryl-CoA Reductase Inhibitors; 0/Pyrroles; 0/antithrombin III-protease complex; 0/von Willebrand Factor; 110862-48-1/atorvastatin; 25812-30-0/Gemfibrozil; 79902-63-9/Simvastatin; 81093-37-0/Pravastatin; 9000-94-6/Antithrombin III; 9001-26-7/Prothrombin; EC 3.4.-/Peptide Hydrolases |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Analysis of the contribution of molecular mechanisms into formation of gonoccocal resistance to tetr...
Next Document: Pathogenetic aspects of severe course of herpetic infection.